We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > anakinra

News List

Kineret receives positive CHMP opinion for treatment of COVID-19 pneumonia pharmatimes
December 17, 2021
The European Medicines Agency has recommended approval for use of Kineret in COVID-19 to the European Commission, which will issue a final decision.
Kineret® improves clinical outcomes in hospitalised patients with COVID-19 pneumonia europeanpharmaceuticalreview
May 07, 2021
Treating moderate to severe COVID-19 pneumonia patients with poor prognosis with Kineret® (anakinra) prevented death and progression to severe respiratory failure.
Sobi launches Kineret for AOSD, SJIA pharmatimes
July 17, 2018
Sobi UK and Ireland has announced the launch of Kineret across the country offering a new treatment option for Adult Onset Stills Disease (AOSD) and Systemic-Onset Juvenile Idiopathic Arthritis (SJIA).